molecular imaging

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clinical Validation of Multimodal Digestive Endoscopy

Enrolling by invitation
  • Rectal Neoplasms
  • +3 more
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Oct 10, 2022

    Healthy Volunteers, Alzheimer, Molecular Imaging Trial in London ([11C]BU99008, Idazoxan, Isocarboxazid)

    Completed
    • Healthy Volunteers
    • +2 more
    • [11C]BU99008
    • +2 more
    • London, United Kingdom
      Centre for Neuropsychopharmacology; Division of Brain Sciences;
    Oct 14, 2021

    Metastatic Breast Cancer, Molecular Imaging Trial in Odense (FDG-PET/CT)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Molecular Imaging
    • FDG-PET/CT
    • Odense, Funen, Denmark
      Marianne Vogsen
    May 22, 2021

    Molecular Imaging Trial in Harbin (68Ga-NODAGA-ZIGF-1R:4:40)

    Unknown status
    • Molecular Imaging
    • 68Ga-NODAGA-ZIGF-1R:4:40
    • Harbin, Heilongjiang, China
      TOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical Un
    Feb 20, 2020

    Molecular Imaging Trial in Harbin (18F-IRS)

    Completed
    • Molecular Imaging
    • 18F-IRS
    • Harbin, Heilongjiang, China
      TOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical Un
    Feb 20, 2020

    Molecular Imaging Trial in Harbin (18F-MPG)

    Unknown status
    • Molecular Imaging
    • 18F-MPG
    • Harbin, Heilongjiang, China
      TOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical Un
    Jun 23, 2019

    Molecular Imaging Trial in Rochester (dietary supplement, other, radiation, drug)

    Completed
    • Molecular Imaging
    • Meal
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Apr 17, 2017

    Molecular Imaging Trial in Harbin (68Ga-NODAGA-Ac-Cys-ZEGFR:1907)

    Unknown status
    • Molecular Imaging
    • 68Ga-NODAGA-Ac-Cys-ZEGFR:1907
    • Harbin, Heilongjiang, China
      TOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical Un
    Sep 24, 2016